Josie Health vs Midi Health: Which One Can Actually Prescribe What You Need?

Josie Health vs Midi Health comes down to the medication path. Josie offers $269–$299 three-month compounded HRT plans fulfilled by licensed pharmacies. Midi charges $250 for a first self-pay visit and $150 for follow-ups, usually prescribing FDA-approved hormone products to a pharmacy you choose. If you have an intact uterus and want systemic estrogen, start with Midi.^[1][9][10]

Here's what almost every comparison of these two gets wrong. They line up price, states, and convenience as if you're choosing between two versions of the same thing. You're not. You're choosing between two different care and medication models, and the product that reaches you can be different at each one.

Who is Josie best for, and who is Midi best for?

Josie is best for a narrower cash-pay reader who knowingly accepts compounded medication, wants a fixed three-month total, and prefers an intake-plus-messaging model. Midi is best for most women who want FDA-approved-first prescriptions, insurance access, a live video visit, or an intact-uterus systemic-HRT plan. Neither is the first stop when symptoms need an examination.

Start with Josie if: you're paying cash, you knowingly want a compounded option, you value a fixed three-month total over insurance uncertainty, and you would rather complete an online intake and communicate by message than schedule a video visit. After a total hysterectomy, an estrogen-only plan may be a fit if your clinician confirms it is appropriate for your surgical and medical history.^[29]

Start with Midi if: you still have a uterus and want systemic estrogen, you want an FDA-approved-first medication path, you have a PPO plan that may cover the visit, you want a scheduled video appointment, or you need a standard pharmacy prescription for an oral, patch, gel, ring, cream, or other route.

Start somewhere else first if: you have unexplained vaginal bleeding or any bleeding after menopause, you need a pelvic or skin examination, or you are trying to use Medicare or Medicaid benefits rather than pay outside them. Postmenopausal bleeding needs prompt clinical evaluation; an online intake should not be used to skip that step.^[27]

Josie Health vs Midi Health: the numbers at a glance

Josie publishes the simpler package price: $269 or $299 for three months. Midi publishes the broader clinical route: $250 for the first self-pay visit, $150 for follow-ups, FDA-approved-first pharmacy prescriptions, and insurance billing for many PPO plans. The table below shows exactly what each headline includes — and what it leaves out.

Decision fact	Josie / Join Josie	Midi Health
Published price	$269 or $299 charged for a three-month HRT plan	$250 first self-pay visit; $150 self-pay follow-up; medication and labs separate
Standard medication lane	Four public HRT products, all labeled compounded	Standard HRT care centers on FDA-approved prescription products sent to a pharmacy
Separate compounded lane	The public HRT catalogue is compounded	Midi Custom Rx separately sells compounded products after a clinical visit
Insurance	Does not accept insurance; says some patients use HSA/FSA funds, subject to account rules	In-network with many PPO plans; exact copay, deductible, coinsurance, and coverage depend on the plan
First clinical interaction	Online intake reviewed by a licensed provider; follow-up by message; no scheduled video visit is promised on the public HRT pages	Scheduled 30-minute first video visit; follow-ups are about 15 minutes
State availability	Provider-stated: all 50 states for HRT	Provider-stated: all 50 states for standard care; testosterone is currently listed in 24 states plus DC
Medicare / Medicaid	No insurance billing; no Medicaid- or Medicare-specific eligibility rule is published on the HRT pages	Medicare beneficiaries may self-pay but cannot submit claims; Medicaid and Medi-Cal patients cannot be accepted, even as self-pay

Provider pages checked 21 August 2026. State availability above is provider-stated, not an independent 50-state licensure audit.^{[1][2][9][14]}

Where our money comes from, before you read another word. We may earn a commission if you start with Midi through an affiliate link on this page. We earn nothing from Josie — no affiliate link, referral fee, or relationship. That asymmetry is why the page names the groups Josie fits better, publishes Midi's own weak points, and tells some readers to choose neither. If every link disappeared, the verdict would stay the same.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

Name check: the consumer brand uses Josie and Join Josie, and its own content also uses “Josie Health.” We use Josie throughout. “Josie Health vs Midi Health” is the comparison query; it is not evidence that the companies use identical business models.

Before we go further: The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

What's the actual difference between Josie and Midi?

Josie offers fixed-price plans built around compounded products prepared and shipped by licensed pharmacies when prescribed. Midi operates more like a virtual medical practice: the standard lane is a video visit followed by FDA-approved prescriptions sent to a pharmacy, while a separate Custom Rx store contains clearly labeled compounded products.^[1][10][11]

That distinction decides your billing model, medication route, pharmacy path, insurance access, cancellation questions, and what you need to verify before paying.

Here is the public medication menu as it stood on 21 August 2026. This table combines the two companies' standard pages, product pages, store pages, prices, routes, approval status, and public disclosure gaps in one place.

What you might need	Josie	Midi
Systemic estradiol patch	Compounded HRT · Transdermal, $269 per three-month plan. The public page does not name the strength, manufacturer, NDC, or dispensing pharmacy.	FDA-approved patch options in the standard HRT lane, prescribed to a pharmacy.
Systemic estradiol cream or gel	Compounded transdermal estradiol cream, $269 per three-month plan.	FDA-approved topical forms in the standard lane. Midi also has separate compounded Custom Rx products, which are not the same lane.
Oral estradiol	No oral estrogen product is published in the HRT catalogue.	FDA-approved pill options are listed in the standard HRT lane.
Progestogen for an intact uterus	A compounded transdermal progesterone-and-estradiol body cream, $299 per three-month plan. No standalone oral progesterone or progestin product is published in the catalogue.	Standard care can include an FDA-approved progestogen prescription. The Store separately offers a compounded oral micronized progesterone capsule from $35 per 30 days.
Vaginal estrogen for local symptoms	Compounded progesterone-and-estradiol vaginal cream, $299 per three-month plan. Strengths are not published on the public page.	Standard care can prescribe FDA-approved vaginal cream, inserts, or a ring to a pharmacy. A separate compounded DHEA/estradiol cream costs $90 per 30 days and is applied to the external vulva.
Testosterone	No testosterone product is published in the HRT catalogue.	Compounded testosterone cream, starting at $100 for a 90-day supply, listed in 24 states plus DC; clinician evaluation and baseline lab work are required; follow-up blood draws are ordered as needed.
FDA-approved finished HRT product in the public catalogue?	No. Every public HRT product is labeled compounded, and Josie states compounded HRT is not FDA-approved.	Yes, in the standard lane. Separate Custom Rx products are compounded and must not be described as FDA-approved.

Source: current Josie HRT category and four product pages; current Midi HRT and Custom Rx pages. Prices and routes verified 21 August 2026.*^{[1][2][3][4][5][10][15][12][13][14]}

Two things need to be said immediately so that table does not get read the wrong way.

First, a fair point for Josie. Every HRT product is visibly labeled compounded. The pages say the products are not FDA-approved, that the FDA does not review compounded medications before marketing for safety, effectiveness, or quality, that Josie does not manufacture them, and that a licensed pharmacy prepares and ships them when prescribed. That disclosure is clearer than the language used by many direct-to-consumer hormone companies.^[3]

Second, a catalogue is a menu, not the whole of clinical practice. “Josie does not publish oral progesterone” is not the same as “a Josie clinician can never prescribe it.” A licensed clinician may recommend something outside the public catalogue. We are auditing what a reader can verify before intake, not predicting an individual clinical decision.

One more phrase that trips people up: a telehealth company is not FDA-approved. A specific finished medication may be FDA-approved for a specific use. A website, intake form, or care program does not receive drug approval.

About testosterone: testosterone is a Schedule III controlled substance in the United States and requires a valid prescription. Midi's current page requires a clinician assessment plus baseline lab work, with follow-up blood draws ordered as needed. It lists availability in 24 states — Arizona, California, Colorado, Delaware, Florida, Illinois, Indiana, Iowa, Kansas, Maine, Maryland, Massachusetts, Nevada, New Jersey, New Mexico, New York, North Carolina, Ohio, Oregon, Pennsylvania, Texas, Utah, Virginia, and Washington — plus the District of Columbia.^[34][14]

Which one fits your situation?

Midi is the stronger starting point for an intact-uterus systemic-HRT decision, an FDA-approved-first preference, a PPO insurance path, or a live video visit. Josie is the narrower cash-pay choice for someone who accepts compounded medication and values a fixed quarterly total plus asynchronous care. The right answer flips when your anatomy, route, plan, or symptoms change.

Find yourself in the table before you read another five sections.

If this is you	Start with	Why
Total hysterectomy, clinician says estrogen-only therapy fits, paying cash	Josie — compare first	The $269 three-month estrogen plans are predictable. Compare the compounded product against an FDA-approved pharmacy prescription before deciding.
Uterus intact, want systemic estrogen	Midi	Its standard lane can pair systemic estrogen with an FDA-approved progestogen through a pharmacy. Josie's published combined systemic option uses transdermal compounded progesterone; the route issue is explained below.
PPO insurance	Midi	It is the only one of the two that bills many commercial PPO plans. Your exact plan still decides the result.
Want FDA-approved medication first	Midi	Josie's public HRT catalogue is entirely compounded. Midi's standard HRT lane is FDA-approved-first.
Vaginal dryness, burning, urinary symptoms, or painful sex only	Midi — usually	Its standard lane includes FDA-approved local vaginal options. Josie offers a compounded progesterone-and-estradiol vaginal cream.
Want testosterone	Midi, where available	Josie publishes no testosterone option. Midi's compounded cream requires a prescription and labs and is limited to its published jurisdictions.
Do not want a scheduled video appointment	Josie	Its public model is an online intake plus messaging.
No insurance and one predictable upfront number matters most	Josie	A $269 or $299 three-month charge is easier to budget than a visit plus unknown medication and lab costs.
Medicare and want covered care	Your existing clinician or an enrolled provider first	Midi is cash-only for Medicare beneficiaries; Josie does not bill insurance.
Medicaid or Medi-Cal	Your plan network first	Midi cannot accept Medicaid or Medi-Cal patients, even as self-pay. Josie does not publish a Medicaid-specific rule; confirm cash-pay eligibility before completing intake.
Unexplained vaginal bleeding or any bleeding after menopause	Prompt clinical evaluation	Do not use an online intake to bypass evaluation of a symptom the FDA says can signal an urgent problem.
Need an examination, imaging, or specialist coordination	In-person or hybrid care	Neither model can perform a physical examination through a screen or form.

Not sure which row is yours? Your uterus status, symptoms, state, route preference, and insurance can flip this answer. Use Find My HRT Path to see the best-fit route and the safety flags that mean online care should not be your starting point.

How much do Josie and Midi actually cost?

Josie charges $269 or $299 for a three-month plan that includes provider review, medication when prescribed, shipping, messaging, and provider-directed dose adjustments. Midi charges $250 for a first self-pay visit and $150 for follow-ups; medication and labs are separate. Josie is easier to price before intake. Midi may cost less with in-network insurance, but that is plan-dependent, not guaranteed.^[1][9][18]

That distinction matters more than the headline number.

First, a correction on Josie's “$89 per month” headline

Josie's HRT category advertises pricing “as low as $89/mo.” The actual product is a $269 three-month plan. The arithmetic is $269 ÷ 3 = $89.67, which the product page describes as about $90 per month.^[1][2]

There is no published $89 monthly HRT payment option. The number you need available for the $269 products is $269. For the combined body cream or vaginal cream, it is $299.

We're not calling the monthly equivalent a trick. Packaged plans are often advertised that way. But if you budget month to month, the card charge matters more than the division problem.

The reproducible first-90-day math

Read this before the table. These are arithmetic scenarios built from current provider-published fees. They do not guess your dose, medication price, lab bill, copay, deductible, coinsurance, approval decision, or number of follow-ups. Where the exact total is unknowable before intake, the table says so instead of inventing a “starting at” figure.

First 90 days	Josie	Midi	What remains unknown
Estrogen-only plan	$269 upfront for one three-month plan	$250 first self-pay visit + medication + any labs; $400 in visit fees if one $150 follow-up occurs in the first 90 days	Medication, dose, pharmacy, labs, and follow-up timing
Josie combined body cream	$299 upfront for one three-month plan	No single bundled equivalent. Standard care is visit fee or insurance cost-share + prescribed estrogen/progestogen + any labs	Exact regimen and pharmacy benefit
Josie vaginal cream	$299 upfront for one three-month plan	Visit fee or insurance cost-share + FDA-approved local prescription; Midi's separate compounded external DHEA/estradiol cream is $90 per 30 days after a visit	Which local product is prescribed and what insurance pays
In-network PPO visit path	Not billed to insurance	Plan-specific copay, deductible, or coinsurance + medication + labs. Midi says the insured average is around $50 per visit, but your plan controls.	Exact eligibility, allowed amount, cost-share, formulary, lab network

The reproducible one-year planning formulas

Planning assumption	Josie	Midi
Four identical $269 three-month plans	$269 × 4 = $1,076	Not comparable without the number of visits, medication price, labs, and insurance
Four identical $299 three-month plans	$299 × 4 = $1,196	Not comparable without the number of visits, medication price, labs, and insurance
Self-pay Midi with one first visit and one follow-up during the year	—	$250 + $150 = $400 in visit fees, plus medication and labs
Self-pay Midi with one first visit and three follow-ups during the year	—	$250 + ($150 × 3) = $700 in visit fees, plus medication and labs
Insured Midi	—	Your cost-share for each visit + pharmacy and lab costs under your exact benefits

These are planning formulas, not promises about treatment frequency. A clinician decides the regimen and follow-up cadence.

Here is the honest cost verdict. Josie publishes the more predictable number. Midi gives insurance a chance to lower the visit and pharmacy costs, but you cannot know the final total from the homepage alone.

If your nervous system needs one figure it can plan around, that is a real advantage for Josie. If you have an in-network plan and want the standard pharmacy system to handle FDA-approved prescriptions, Midi may be the better financial path. The coverage check — not the sticker price — decides which sentence is true for you.

Does Josie take insurance? Does Midi?

Josie does not accept insurance. Midi is in-network with many PPO plans, but exact coverage depends on the specific plan, state, deductible, copay, and coinsurance. Midi's current pages allow Medicare beneficiaries to self-pay without submitting claims and exclude Medicaid and Medi-Cal patients even as self-pay.^[1][9][17]

There are three separate money doors here, and most comparisons look at only one.

Money door	Josie	Midi
The clinical service	Cash-pay only; provider review is bundled into the three-month plan when treatment proceeds	In-network for many PPO plans; self-pay is $250 for the first visit and $150 for follow-ups
The medication	Bundled into the plan when prescribed; Josie does not bill a pharmacy benefit	Standard prescriptions can be sent to a pharmacy and processed under the patient's drug benefit; Custom Rx products are separately priced and generally cash-pay
HSA/FSA	Josie says some patients use HSA/FSA funds and tells them to confirm with the account provider	Midi accepts HSA/FSA payment for eligible services; the account's rules still control
Medicare	No insurance billing	Out of network; current operational pages say beneficiaries may self-pay but cannot submit claims for visits, medications, labs, or associated services
Medicaid / Medi-Cal	No insurance billing; no Medicaid-specific public eligibility rule found on the HRT pages	Cannot be accepted, even as self-pay
Counts toward deductible or out-of-pocket maximum	Not processed through Josie as an insurance claim; ask the plan whether any patient-submitted reimbursement is possible	In-network claims may count according to the exact benefit design

Two Midi pages still disagree about Medicare

We're pointing out a contradiction on the company that may pay us, because you would want to know.

Midi's current pricing page, HRT page, and Medicare help article say Medicare beneficiaries may be seen as self-pay patients but cannot submit claims related to Midi visits, medications, labs, or services. Those pages were current in 2026.^[9][10][17]

A still-live cost article published in August 2024 and updated in December 2024 says Midi could not treat Medicare, Medicaid, or Medi-Cal patients even as self-pay. That older Medicare sentence conflicts with the current operational pages.^[21]

For this article, the current 2026 pricing and help pages are the source of truth: Medicare may use Midi as self-pay; Medicaid and Medi-Cal may not. Because the older page is still live, Medicare beneficiaries should get the current answer from support in writing before booking.

What about an HMO?

Midi's older cost article says it is not in-network with HMO plans. The current pricing page tells patients to use the plan-and-state checker because coverage varies by exact plan. Do not rely on a carrier logo or the word “HMO” alone; run the specific plan through the checker.^[21][9]

How to check Midi coverage in the right order

1. Use Midi's plan-and-state checker on the pricing page.
2. Upload your insurance card during registration. Review the result before you book.
3. Call your insurer and document the answer. Write down the representative's name, date, and reference number.

Ask these five questions:

• Is Midi in network for my exact plan in my state?
• What is the allowed amount for a new-patient specialist telehealth visit?
• Does my deductible, copay, or coinsurance apply?
• Are the specific estradiol and progestogen products my clinician may prescribe on my formulary, and at what tier?
• Which laboratories and pharmacies are in network for me?

That last question can erase the savings if it is ignored. An in-network visit does not automatically make every lab or prescription in-network.

Objection resolved: “Will insurance actually help?” You now know what Midi can bill, what it cannot promise, and what to ask before a claim exists. Check Midi coverage for your plan and state (affiliate link; the destination performs an eligibility check before booking).

What does compounded HRT mean — and does it matter here?

A compounded medication is prepared by a pharmacy for an individual patient and is not an FDA-approved finished drug. The FDA does not review the finished compounded product for safety, effectiveness, or quality before it is marketed. Josie's public HRT catalogue is compounded; Midi's standard HRT lane is FDA-approved-first, with separate compounded Custom Rx options.^{[27][1][10][11]}

This is the word the whole comparison turns on, so it needs exact language.

Question	FDA-approved medication	Compounded medication
Premarket status	FDA has reviewed evidence for the approved use and the manufacturer's quality and production controls	The finished compounded product is not FDA-approved and does not undergo FDA premarket review
Why it exists	Commercially manufactured in an approved strength, dosage form, and labeling framework	Prepared for an individual prescription, often when a patient needs a formulation or ingredient profile not commercially available
Oversight	Federal drug-approval, manufacturing, labeling, and postmarket requirements apply	Pharmacy and state/federal compounding requirements apply, but they are not the same as drug approval
Insurance path	Often eligible for normal pharmacy-benefit processing, subject to formulary and plan rules	Coverage is less predictable; both companies' custom compounded lanes should be treated as cash-pay unless the plan confirms otherwise
What the label “bioidentical” tells you	Nothing about approval status	Nothing about approval status

“Bioidentical” does not answer the FDA question

“Bioidentical” describes molecular structure. It does not tell you whether the finished product was FDA-approved. FDA-approved estradiol and micronized progesterone products exist, and compounded hormone products also exist. The question that matters is:

Is this specific finished product FDA-approved, or was it compounded for me?

FDA recommends FDA-approved hormone therapies and says it does not have evidence that compounded “bioidentical” products are safer, more effective, or even established as safe and effective compared with FDA-approved hormone therapy. The Menopause Society makes the same practical distinction: FDA-approved bioidentical products exist, while custom-compounded products can have less predictable dosing and absorption.^[27][28]

When compounding is a reasonable clinical conversation

Compounding can make sense when:

• a needed strength or dosage form is not commercially available;
• a documented allergy or intolerance involves an inactive ingredient in available products;
• an approved product is unavailable because of a shortage;
• a clinician has a patient-specific reason and explains the approval-status and quality trade-off.

The Menopause Society's 2022 position statement says patient preference by itself should not be the reason to choose compounded therapy when an approved option can meet the clinical need. ACOG's 2023 clinical consensus advises against routinely prescribing compounded menopausal hormone therapy when FDA-approved formulations exist.^[29][30]

What does not answer the question: “natural,” “personalized,” “provider-reviewed,” “bioidentical,” or the convenience of putting two hormones in one tube.

Marketing phrases that should slow you down

At any company, not just these two:

• language that presents a compounded product as a generic version of an FDA-approved brand;
• “just like an FDA-approved patch”;
• “FDA-regulated” placed where a reader expects “FDA-approved”;
• “safer because it is bioidentical”;
• unqualified product-efficacy claims with no product-specific evidence.

Those phrases are not harmless word choices. In February 2026, the FDA cited Josie's marketing of compounded GLP-1 drugs for implying a relationship to approved drugs that the agency said had not been established. That letter did not concern Josie's HRT products, but the marketing lesson applies across compounded-drug categories.^[35]

If you still have a uterus, what protects your uterine lining?

Systemic estrogen without adequate progestogen raises the risk of endometrial hyperplasia and cancer in a woman with an intact uterus. Josie's published combined systemic product is a compounded progesterone-and-estradiol cream, but the page does not disclose the progesterone form, strength, or dose. Current British Menopause Society guidance says transdermal micronized progesterone is unlikely to provide sufficient endometrial protection. That makes the exact formulation, route, dose, schedule, and monitoring a before-you-pay question.^[27][31][32]

This is the most important section on the page. Read it even if you skip everything else.

First, the fair framing belongs first. A catalogue is a menu, not the whole of clinical practice. A Josie clinician may prescribe a different progestogen route or refer a patient elsewhere. We are comparing what is published and purchasable before intake. There is no provider CTA in this section for exactly that reason.

What Josie publishes

Josie's estradiol cream page correctly says that a woman with a uterus generally needs a progestogen with systemic estrogen. Its estradiol patch page says progesterone would be prescribed separately if needed. Its published combined systemic option is a compounded transdermal progesterone-and-estradiol body cream priced at $299 per three months.^[3][2][4]

The public catalogue does not publish:

• a standalone oral progesterone capsule;
• a progestin tablet;
• a hormonal-IUD pathway;
• the progesterone strength in the body cream;
• the prescribed dose or schedule;
• an endometrial-monitoring protocol.

That does not prove those options are unavailable after clinical review. It means a reader cannot verify them before entering the process.

What the route evidence says

Evidence source	What it establishes	Why it matters here
FDA menopause guidance	Estrogen raises endometrial-cancer risk in a woman with a uterus; adding a progestin lowers that risk	The regimen needs an adequate progestogen plan, not a vague mention of “balance”
British Menopause Society, May 2026	Transdermal micronized progesterone has variable absorption and is unlikely to provide sufficient endometrial protection; it should not be used transdermally for that purpose	Josie's page names a transdermal progesterone cream but not the progesterone form or dose, so a reader cannot verify that it matches an evidence-supported protection regimen
Stute et al., 2016 systematic review and expert recommendations	Transdermal micronized progesterone does not provide endometrial protection; specific oral and vaginal regimens have evidence in defined doses and schedules	The word “progesterone” alone does not establish an evidence-supported route, dose, or schedule
The Menopause Society, 2022	The progestogen dose and duration must match the estrogen dose and regimen; compounded therapy introduces dosing and quality concerns	A clinician needs to name the exact plan and monitoring, not only the ingredients

The British Menopause Society is a UK clinical body, not a US regulator. We use it here because its May 2026 guidance directly evaluates the route Josie publishes, and the underlying route conclusion is also reflected in peer-reviewed evidence.^[31][32]

The objection has two separate parts

Almost every comparison collapses these into one argument. That hides the decision.

1. The route question: Does the progestogen reach the endometrium reliably enough, in the prescribed dose and schedule, to reduce estrogen-related risk? This is the problem with relying on a compounded progesterone cream through the skin without a disclosed evidence-supported formulation, dose, and schedule.
2. The approval and quality question: Was the finished product reviewed by the FDA for safety, effectiveness, quality, and manufacturing consistency? This issue applies to every compounded product, including Midi's compounded oral progesterone capsule.

Midi's compounded oral capsule avoids the transdermal-cream route objection, but its exact prescribed dose still has to be adequate and the finished product remains compounded. Midi's standard FDA-approved prescription lane avoids both the compounded-product issue and the transdermal-progesterone issue.

That is the honest version. It is less flattering to the company that may pay us than most affiliate comparisons would write.

The exact question to ask either provider

Copy this into your intake message:

“I have a uterus. If I use systemic estrogen, exactly what will reduce my endometrial risk — which medication, which route, what dose, how many days per month, and what monitoring will you use?”

A clear answer names the product, route, dose, schedule, and follow-up plan. A vague answer is information.

Is Josie's estradiol patch FDA-approved?

No — not according to Josie's current public page. The patch is labeled “Compounded HRT · Transdermal,” and the page's FAQ says compounded HRT is not FDA-approved. The page does not publish the estradiol strength, manufacturer, NDC, dispensing pharmacy, or a sample label.^[2]

This is a direct correction to the uncertainty other reviews create around the word “patch.” A patch can be FDA-approved or compounded. Josie's page identifies this one as compounded.

Josie also says it does not manufacture compounded medication and that a licensed pharmacy prepares and ships medication when prescribed. That is the accurate company-level description. Do not write that Josie manufactures or compounds the patch itself.^[2]

Before paying, send one message:

“Which licensed pharmacy prepares my patch, what estradiol strength and dosing schedule will be dispensed, and is the finished patch compounded rather than an FDA-approved manufactured patch?”

That question is not hostile. It is the minimum information needed to compare the $269 plan against an FDA-approved patch prescribed through a retail pharmacy.

What about vaginal dryness and painful sex?

Josie offers a compounded progesterone-and-estradiol vaginal cream for $299 per three months. Midi's standard lane can prescribe FDA-approved vaginal estrogen cream, inserts, or a ring to a pharmacy. Midi also sells a separate compounded DHEA/estradiol cream for $90 per 30 days, but that product is applied to the external vulva, not inside the vagina.^[5][10][13]

For genitourinary syndrome of menopause — dryness, burning, irritation, urinary symptoms, and discomfort with sex — the route distinction matters as much as the price.

Product path	Where it is used	Approval status	Public price
Josie progesterone + estradiol vaginal cream	Vaginally; Josie describes it as local	Compounded, not FDA-approved	$299 per three-month plan
Midi standard vaginal estrogen prescription	Product-dependent: vaginal cream, insert, or ring	FDA-approved options	Visit/insurance cost + pharmacy price; exact amount depends on product and plan[15]
Midi Custom Rx DHEA/estradiol cream	External vulva once daily	Compounded, not FDA-approved	$90 per 30-day supply after a visit

The Menopause Society's 2022 position statement says a progestogen is generally not indicated with recommended-dose low-dose vaginal estrogen, although longer-term randomized-trial data beyond one year are limited. Josie's public vaginal-cream page does not publish the strength of either hormone, so we cannot tell from the page whether its progesterone serves a local formulation purpose, reflects a systemic dosing intent, or is simply the company's product design.^[29][5]

We are not calling Josie's product unsafe. We have not seen the dispensed label, strength, dose, or certificate of analysis. We are saying the progesterone component is not explained on the public page, and that deserves a direct answer:

“Why does this vaginal product include progesterone, what is the strength and dose of each hormone, and is it intended as local or systemic treatment?”

For a deeper answer, see Vaginal estrogen: forms, safety, and what to ask.

What actually happens at your first visit?

Midi starts with a scheduled 30-minute video visit in which a clinician reviews symptoms, history, and goals; follow-ups are about 15 minutes. Josie starts with an online intake reviewed by a licensed provider, with questions handled by message; Josie says most patients hear from a provider within 24 to 48 hours. Neither format is better in the abstract. They serve different people.^[9][8]

The Josie path

1. Choose an HRT path or begin the intake.
2. Complete the online form with symptoms, health history, and goals.
3. A licensed provider reviews the submission; Josie says its licensed clinicians are supervised by Dr. Ana Lisa Carr, MD.
4. The care team follows up by message if more information is needed.
5. If treatment is prescribed, a licensed pharmacy prepares and ships the compounded medication.
6. Messaging and provider-directed dose adjustments are included in the plan price.

No scheduled video visit is promised on the public HRT pages. That is a benefit if you hate appointments and a limitation if you need a real-time conversation.

The Midi path

1. Check your state and insurance plan.
2. Book a virtual visit.
3. Complete the health questionnaire.
4. Attend the 30-minute first video visit.
5. Complete tests if the clinician orders them.
6. Fill standard prescriptions at a pharmacy; Custom Rx products follow their separate fulfillment path.
7. Book 15-minute follow-ups when clinically needed.

Who should pick which format?

Choose the live video visit if your history is complicated, several symptoms are tangled together, you have been dismissed before and want to ask questions out loud, or you want a scheduled clinical conversation before a prescription decision.

Choose the form-and-message model if convenience is the priority, your situation is straightforward, and you genuinely prefer asynchronous communication.

Choose in-person or hybrid care if you need an examination, imaging, urgent evaluation, or coordination with an existing specialist.

Two honest frictions, one on each side

Midi uses two patient systems. Its help center distinguishes the Midi Portal for scheduling and administrative tasks from the athenahealth Patient Portal for clinical records and messages. That is manageable, but it creates a learning curve and a real “which portal has this?” moment.^[20]

Josie's “unlimited messaging” needs definition. It is included, but the public HRT pages do not publish an emergency-response promise, guaranteed response time for every clinical message, scheduled follow-up cadence, or a replacement for in-person care. “Unlimited” describes the number of messages, not the speed or scope of the care.

Do you need lab work at either one?

A routine hormone panel is not a universal gateway to standard menopause HRT. Josie says labs may be recommended based on history; Midi orders testing when clinically indicated and excludes labs from the visit price. Midi's testosterone program is different: its current page requires baseline lab work, with follow-up blood draws ordered as needed.^[1][18][14]

For women in the usual menopausal age range with a typical symptom and menstrual history, diagnosis is generally clinical. Hormone levels can fluctuate during perimenopause, so a single FSH or estradiol result may not answer the question the patient thinks it will. Testing becomes more important when the age, pattern, symptoms, diagnosis, safety history, or proposed treatment calls for it.^[33]

Lab question	Josie	Midi
Universal panel before standard HRT?	No universal panel is published; labs may be recommended	No universal panel is published; tests are ordered when clinically indicated
Included in published price?	No separate lab price or named lab partner is published	No; Midi states labs are separate from the visit price
Testosterone exception	No testosterone product published	Baseline lab work required; follow-up blood draws ordered as needed for the compounded testosterone program
What to ask	Which test, why, where, and who pays?	Which test, why, in-network lab, and expected patient cost?

The genuine limitation is the same at both companies: telehealth cannot examine tissue through a form or video. Vulvar skin disorders, infections, pelvic-floor pain, lesions, and other conditions can resemble “just menopause.” When something needs to be looked at, it needs to be looked at.

Who are the clinicians, and how do you check them yourself?

Josie publicly names Dr. Ana Lisa Carr, MD, MBA, as the physician supervising its licensed clinicians; her federal NPI is 1689841744 and her primary taxonomy is family medicine. Midi publishes a roster of more than 550 board-certified clinicians and has received NCQA Credentialing Accreditation. Both present verifiable clinical infrastructure, but Midi discloses much more of the network.^{[7][24][22][23]}

Before the comparison, the credit belongs where it belongs.

Publishing a named physician and license information puts Josie ahead of telehealth brands that expose no clinician identity at all. Dr. Carr's NPI can be checked in the federal registry. That does not mean she personally reviews every intake; Josie's wording is that licensed clinicians review cases under her supervision.

How to check a telehealth clinician in about two minutes

1. Find the clinician's full name on the provider site or your appointment confirmation.
2. Search the NPPES NPI Registry by name or NPI number.
3. Read the primary taxonomy. It shows the specialty category registered with the federal identifier.
4. Check the active state license with the relevant medical or nursing board.
5. Match the name on the prescription or visit record to the person you looked up.

The NPI is a useful identity check. It is not a quality score, disciplinary-history search, or promise that the clinician has a specific menopause credential.

The narrow, honest disclosure comparison

We are comparing what each company publishes, not declaring one clinician competent and another incompetent. Family physicians, internists, gynecologists, nurse practitioners, and other properly licensed clinicians can all provide menopause care within their training and scope.

Public disclosure	Josie	Midi
Named supervising or clinical leader	Dr. Ana Lisa Carr, MD, MBA	Named clinical leadership plus a public clinician roster
Public clinician count	One supervising physician is prominently named; the total clinician count is not published on the HRT pages	More than 550 board-certified clinicians
Individual clinician profiles	No searchable public HRT roster found	Searchable roster with clinician profiles
Menopause-specific credentials disclosed	None found on the Josie pages reviewed	At least one public profile displays the NCMP menopause credential; other profiles list women's-health certifications
Independent credentialing accreditation	None found on the pages reviewed	NCQA Credentialing Accreditation
Care format	Licensed-provider intake review plus messaging	Scheduled video visit with the assigned clinician

The difference is disclosure depth, not a verdict on an unseen appointment. Josie gives you one real physician to verify. Midi gives you a large public network to inspect before booking.

Did either company get in trouble with a regulator?

Yes — both have a public advertising record from February 2026. The FDA sent Josie a warning letter about marketing compounded semaglutide and tirzepatide. Five days later, the National Advertising Division reported that Midi permanently discontinued a challenged Instagram claim during an inquiry. Neither action concerned the safety of a menopause hormone product.^[35][37]

We checked both companies against the same kind of public record. Publishing only the non-affiliate's problem would turn a comparison into a hit piece.

Record	Josie	Midi
Body	US Food and Drug Administration	National Advertising Division of BBB National Programs
Date	20 February 2026	25 February 2026
Type	FDA warning letter, MARCS-CMS 717986	Routine-monitoring advertising inquiry
Subject	Marketing of compounded semaglutide and tirzepatide	An Instagram claim that invoked a 91% symptom-relief figure
Core issue	FDA said the website presentation could imply Josie compounded the drugs and could imply an unapproved compounded product had the same evaluated status as an approved drug	Midi permanently discontinued the express and implied claims during the inquiry; NAD did not review their merits
Did it concern HRT-product safety?	No	No
Current public status	FDA requested a response within 15 working days; our 21 August 2026 search did not locate a public close-out letter	The challenged claims were permanently discontinued

What the Josie letter does — and does not — establish

A warning letter is not a recall, fine, lawsuit, criminal charge, or final finding of liability. The letter concerned compounded GLP-1 marketing, not Josie's HRT catalogue.^[35]

It also was not an isolated one-company event. In March 2026, the FDA announced that it had warned 30 telehealth companies over illegal or misleading marketing of compounded GLP-1 products. Josie was part of that sector-wide campaign.^[36]

That context does not erase the letter. It makes the proportion accurate.

What Josie's site says now

On 21 August 2026, Josie's live pages said:

• Josie is not a compounding pharmacy;
• compounded medications, when prescribed, are prepared by licensed compounding pharmacies;
• Josie does not manufacture compounded medications;
• compounded medications are not FDA-approved;
• compounded medications are not FDA-approved generics.

Those edits directly address the categories of language the FDA criticized. A website correction is not the same as an FDA close-out letter. Both facts belong on the page.

What the Midi inquiry does — and does not — establish

NAD's record says Midi permanently discontinued the challenged Instagram claim during the inquiry, so NAD did not decide whether the claim was substantiated. It was an advertising case, not a drug-safety action, licensure action, or finding that Midi's care model was illegitimate.^[37]

We will not repeat the withdrawn outcome statistic as sales copy. A claim a company has stopped using should not keep circulating because an affiliate page quoted it.

What do the reviews actually show?

On 21 August 2026, Midi had 1,557 Trustpilot reviews and a 4.1 TrustScore. Josie had five reviews and a 3.8 TrustScore. Midi's denominator is more than 300 times larger, so the scores should not be treated as equally mature evidence. Trustpilot also says Josie invites customers to review, while Midi has no recent history of doing so.^[25][26]

This is where comparison pages usually print two decimals side by side and pretend the numbers mean the same thing. They do not.

Review signal, checked 21 Aug 2026	Josie	Midi
Trustpilot reviews	5	1,557
TrustScore	3.8	4.1
5-star share	60%	75%
1-star share	20%	16%
Review invitation status shown by Trustpilot	Invites customers to review	No recent history of asking for reviews
Response to negative reviews	100%; typically over one month	93%; typically within one week
What the profile covers	The whole Josie business, including weight-management experiences — not an HRT-only sample	The whole Midi service — not an HRT-only clinical-outcomes study

Five reviews can reveal individual experiences. They cannot support a stable population-level conclusion. Midi's 1,557 reviews provide a much broader service signal, but they still remain self-selected consumer reviews, not medical evidence.

Three process-only review excerpts — not efficacy evidence

We use these only to show what real customers said about process and communication. They do not prove safety, clinical quality, or a typical outcome.

• Josie, Tami, 19 June 2026, unprompted Trustpilot review: getting started was “really quick and simple,” and she described prompt, discreet shipping.
• Josie, Kerry, 26 June 2026, verified Trustpilot review: the title asked for “someone answering when I ask questions,” and the review described two unanswered clinical questions. Josie replied that clinical questions require licensed-provider review and agreed follow-up should be timely.
• Midi, Erin Welch, 18 August 2026, unprompted Trustpilot review: she wrote that her nurse practitioner “sets clear expectations” and helped with insurance changes.

That is a fairer use of reviews than publishing hot-flash, sleep, weight, libido, or energy testimonials as though a stranger's outcome predicts yours.^[25][26]

The unsourced number in Josie's footer

Josie's live pages display “Average Rating 4.9/5.” The footer does not publish the source, review count, sampling method, date range, or a link to the underlying reviews.^[3]

We are not calling the number fake. It may come from an internal survey. The publishable point is narrower: a reader cannot independently audit it. Do not treat it as independently verified or compare it with Trustpilot as if they are the same dataset.

Company-owned testimonials are a different evidence category

Midi's pricing page discloses that the featured patients became Midi Ambassadors and may receive free products or swag. That is a material-connection disclosure and it belongs beside the testimonials.^[9]

Josie's on-site HRT testimonials use first names and initials with “verified client” labels but do not publish a review platform, sample size, or methodology. Company-owned testimonials can illustrate voice. They should not be used to prove medical efficacy or to build a numeric rating.

What happens to your money if you change your mind?

Josie's intake is free, but its product FAQs say an $80 consultation fee applies if a provider approves the care plan and the patient then declines treatment. Josie's pages also say “cancel anytime,” while its short public Terms do not explain refunds, cancellation mechanics, reorder timing, or renewal. Midi's standard visits are pay-per-visit, but its Terms say selected products or services may renew automatically.^[3][6][16]

The $80 Josie gate

The fee is not charged for opening the page or merely beginning an intake. Josie says it applies at one specific moment: a licensed provider approves the care plan and the patient then decides not to proceed.

Where you stop	Published charge
Do not start the intake	$0
Complete the intake and are not approved	$0 under the wording published on the product pages
Are approved and proceed	$269 or $299 plan price, depending on the product
Are approved and then decline treatment	$80 consultation fee

The practical instruction is not “avoid Josie.” It is decide what you still need answered before submitting the intake, not after approval.

What “cancel anytime” does not tell you

Josie's product pages display “cancel anytime.” Its Terms of Service, last updated 15 January 2026, contain a short payments clause but no published:

• refund policy;
• cancellation procedure;
• subscription or auto-renewal clause;
• reorder schedule;
• partial-refund rule;
• governing-law clause;
• arbitration clause.

The gap does not prove a bad policy. It proves the public contract does not answer the question.

Use this test with every telehealth company:

Is the money term you are relying on in the contract or only in marketing copy?

Before paying Josie, ask support to state in writing whether the three-month plan auto-renews, how reorders work, what “cancel” stops, and whether any refund exists after approval, prescribing, compounding, or shipping.

Midi's exit terms are different, not nonexistent

Midi's standard clinical visits are billed one at a time. Its help center says to cancel or reschedule an appointment at least 24 hours ahead to avoid a fee.^[19]

Midi's Terms, last updated 23 July 2026, also say certain products and services may renew automatically. The Terms use a two-day cancellation cutoff in the general prescription-subscription section and a three-business-day cutoff in the store-subscription section; they also say partial-period refunds generally are not provided. That matters for Custom Rx or any checkout that presents a recurring product, so the exact product and checkout terms control.^[16]

Objection resolved: “Can I get out?” Josie's $80 decision point and missing public cancellation mechanics are now visible; Midi's appointment and recurring-product rules are visible too. Run your situation through Find My HRT Path before you enter either intake — there is no provider commitment inside the tool.

What if you're on Medicare or Medicaid?

Neither is usually the strongest value if you need public-insurance benefits to apply. Midi lets Medicare beneficiaries self-pay but bars submission of claims; it cannot accept Medicaid or Medi-Cal patients even as self-pay. Josie does not bill insurance and publishes no Medicare- or Medicaid-specific HRT rule, so eligibility and total cash responsibility need to be confirmed before intake.^[17][1]

We're not going to dress this up.

Medicare

Midi's current 2026 pages say a Medicare beneficiary can use the service as a self-pay patient, but cannot submit claims related to Midi visits, prescriptions, laboratory work, or associated services. That means the $250/$150 self-pay visit prices apply unless Midi states otherwise at booking.^[9][17]

Josie is already cash-pay. Medicare does not change the published $269/$299 plan structure.

The better first move when cost matters: ask your current primary-care clinician, gynecologist, or another Medicare-enrolled clinician whether they can evaluate you and prescribe through your normal pharmacy benefit. Then confirm the exact drug and tier with your Part D plan. Do not assume coverage from a general drug name; formularies and utilization rules differ.

Medicaid and Medi-Cal

Midi says it cannot treat Medicaid or Medi-Cal patients, even when they offer to self-pay. That is an eligibility exclusion, not merely a refusal to bill the plan.^[17]

Josie does not publish the same exclusion on its HRT pages, but it also does not bill Medicaid. A Medicaid beneficiary should confirm whether Josie can legally and operationally accept the case as cash-pay before completing the intake, then compare that answer with covered clinicians in the plan network.

There is no affiliate link in this section. A reader trying to use public benefits does not need a sales pivot disguised as help.

What's the catch with the one we recommend?

Midi's first self-pay visit costs $250 — nearly the full price of a three-month Josie plan — and it does not include medication or labs. Midi cannot quote a true all-in total before it knows your insurance, treatment, pharmacy, testing, and follow-up needs. Its standard care also uses two portals. Those are real frictions, not footnotes.^[9][20]

We have been demanding of Josie. The company that may pay us gets the same treatment.

The flaw, stated plainly

A $250 Midi visit buys a scheduled clinical evaluation and care plan. It does not buy the prescription product. It does not buy laboratory work. A $150 follow-up may be needed for monitoring, changes, or continued care. If insurance rejects or reprices a claim, the number the reader expected can change.

Midi says its eligibility result and cost information depend on the exact benefits plan. “In-network” is not the same as “free,” and an insurer's allowed amount, deductible, copay, coinsurance, formulary, and lab network all remain in play.^[9][18]

If predictability is your first priority, Josie is better at it. The $269 or $299 plan total is visible before intake, and we earn nothing when you choose it.

What the higher uncertainty buys

Midi's standard lane works through a familiar medical and pharmacy structure:

• a scheduled video visit;
• FDA-approved prescription options;
• a pharmacy you can choose for standard prescriptions;
• the possibility of commercial-insurance billing;
• a broader published menu of routes;
• a large public clinician roster.

That structure is why Midi wins for most readers on this specific comparison. Not because it is always cheaper. Not because insurance always works. Because it gives the intact-uterus, FDA-approved-first reader more medication paths without forcing the entire plan into a compounded package.

You're not buying a medication bundle. You're paying for a clinical visit, then filling the prescription through the normal pharmacy system. Future refills, monitoring, or changes may still require follow-up; the point is the separation between care and product, not a promise of permanent refills.

Does that sound like your situation? Check whether Midi is in network for your exact plan and state (affiliate link).
No insurance, no scheduled video, and a clinician has confirmed a compounded cash-pay plan fits? See Josie's current HRT plans (editorial link; no affiliate relationship).
Need a different route or public-insurance option? Use the full online HRT provider comparison instead of forcing either of these to fit.

How did The HRT Index compare Josie and Midi?

We read both companies' live pricing, HRT, product, insurance, help-center, clinician, and legal pages on 21 August 2026. We checked the FDA and NAD records, the federal NPI registry, current Trustpilot profiles, and medical claims against the FDA, The Menopause Society, peer-reviewed literature, and current clinical guidance. We did not enroll, pay, or receive care.

This page follows The HRT Index Verification Standard: read every published price, separate FDA-approved from compounded on every row, verify state and insurance language against current provider pages, check material regulatory records, and re-check top providers monthly and the full roster quarterly.

We evaluate providers on five pillars, in this exact order: clinical legitimacy, care quality, medication fit, price transparency, access. We do not turn them into a numeric score. A score would hide the decision rules that matter here.

Pillar	Public-evidence edge	Why
Clinical legitimacy	Midi	Both use licensed clinicians. Midi publishes a 550+ clinician roster and NCQA Credentialing Accreditation; Josie names a verifiable supervising physician but publishes a thinner network record.
Care quality	Midi for live clinical depth; Josie for asynchronous convenience	Midi publishes a 30-minute first video visit and 15-minute follow-ups. Josie publishes provider review and unlimited messaging without a scheduled visit. The better model depends on what the patient needs.
Medication fit	Midi for most; Josie for a narrow cash-pay compounded fit	Midi's standard lane spans FDA-approved pills, patches, rings, creams, and gels and can add an appropriate progestogen. Josie's public HRT catalogue has four compounded products and no published oral or standalone progestogen option.
Price transparency	Josie	Exact three-month totals and inclusions are visible. Midi publishes exact visit fees but cannot publish the complete medication, lab, and insurance total.
Access	Split	Both state nationwide standard availability. Josie is simpler for cash-pay asynchronous access. Midi opens a PPO lane but excludes Medicaid/Medi-Cal and treats Medicare only as self-pay.

Provider-stated vs independently checked

Claim	What the provider states	What we independently checked
Josie prices and HRT status	$269/$299 three-month plans; all public HRT products compounded	Read all four live product pages and their expanded FAQs on 21 Aug 2026
Josie state availability	All 50 states	Confirmed the statement exists; did not audit every clinician/entity license in 50 states
Josie clinician identity	Dr. Ana Lisa Carr supervises licensed clinicians	Matched her name and NPI 1689841744 in the federal registry
Midi prices and insurance	$250/$150 self-pay; many PPO plans; Medicare self-pay; no Medicaid/Medi-Cal	Read current pricing, HRT, and help pages; documented the conflict with the older cost article
Midi medication lanes	FDA-approved standard HRT plus separate compounded Custom Rx	Read the standard HRT page, Store, progesterone, DHEA/estradiol, testosterone, and Terms pages
Regulatory records	Provider sites do not control these records	Checked the FDA warning letter, FDA 30-company announcement, and NAD decision directly
Review signals	Company sites publish testimonials and Josie shows an unsourced 4.9/5 footer	Checked both Trustpilot profiles, counts, TrustScores, invitation status, and response data on 21 Aug 2026

What we did not do

We did not enroll at either company. We did not complete an intake, submit insurance, attend a visit, pay the $80 Josie fee, buy a plan, order labs, receive a prescription, or inspect a dispensed label.

We could not independently confirm:

• every state license behind either nationwide claim;
• the pharmacy, strength, dose, or label for a Josie HRT order;
• whether Josie's patch is prepared in the same way for every patient;
• the source or sample behind Josie's footer rating;
• any reader's exact Midi insurance result;
• a total cost that depends on intake, dose, pharmacy, lab, or plan benefits;
• whether an FDA close-out letter will appear after this verification date.

Where the evidence stops, the sentence stops.

Josie Health vs Midi Health: our verdict

For a woman with an intact uterus who wants systemic estrogen, Midi Health is the better starting point because its standard lane can prescribe FDA-approved estrogen and an appropriate progestogen through a pharmacy. For a cash-pay woman after a total hysterectomy who knowingly accepts compounded medication and wants one predictable three-month total without a scheduled video visit, Josie can be the simpler fit.

That is an editorial conclusion based on the verified facts above. It is not medical advice or a substitute for a clinician who knows your history.

Let's put it as plainly as possible.

Midi is the better default for most women choosing between these two. Not because it always costs less. It does not. Not because insurance always works. It does not. Midi wins because the standard lane separates the clinical visit from the medication, uses FDA-approved prescriptions, offers more routes, and gives the intact-uterus reader a clearer progestogen path.

Josie wins price predictability outright. The plan is $269 or $299 for three months, with the provider review, prescribed medication, shipping, messaging, and dose adjustments included. If you are cash-pay, prefer asynchronous care, and have a clinical reason to choose a compounded product, that simplicity is real. Compare it with an FDA-approved pharmacy route before paying, but do not pretend the fixed number has no value.

For two groups, the answer is not a provider CTA. If you are trying to use Medicare or Medicaid benefits, start inside that network. If you have unexplained bleeding or any bleeding after menopause, get prompt clinical evaluation before turning the symptom into an online HRT shopping decision.

You may have spent months hearing that the symptoms are normal, stress, age, or something you should simply endure. You are not difficult for wanting an actual plan. Both companies exist because women got tired of waiting, and both will fit some of them.

The question was never which logo wins.

It is which model can deliver the medication path, clinical conversation, and payment route you need — without hiding the part that could change the decision.

Now you know how to tell.

Ready to test the insurance route before booking? Check Midi coverage for your exact plan and state (affiliate link). The check happens before the visit decision.

Frequently asked questions

Is Josie Health legit?

Yes, in the limited sense a reader usually means by “legit”: Josie is a real telehealth business that names a supervising physician, uses licensed providers, states medication is prescribed only when clinically appropriate, and says licensed pharmacies prepare and ship compounded medication. That does not mean every applicant is approved, every product is FDA-approved, every plan fits, or every public marketing claim is independently verified. Josie's HRT products are compounded; company legitimacy and drug-approval status are separate questions.^[7][1]

Is Midi Health legit?

Yes. Midi publishes a roster of more than 550 board-certified clinicians, a scheduled clinical-care model, current pricing and insurance rules, and NCQA Credentialing Accreditation. Its real limitations are cost uncertainty, insurance variation, separate medication and lab charges, two portals, and public-program restrictions — not an absence of clinical infrastructure.^[22][23][9]

Which is cheaper, Josie or Midi?

Josie is cheaper to predict: $269 or $299 covers one three-month plan. Midi may be cheaper with in-network insurance, but its true total is the visit cost-share plus medication, labs, and any follow-ups. For self-pay, Midi's first visit is $250 and follow-ups are $150 before medication or labs. Do not declare a winner until you know whether Midi is in network and what regimen is being compared.

Does Josie Health take insurance?

No. Josie says it operates outside traditional insurance. Its HRT plan price includes provider review, medication when prescribed, shipping, messaging, and provider-directed adjustments. Josie says some patients use HSA/FSA funds, but the account administrator's rules decide eligibility.^[1]

Does Midi Health take insurance?

Midi is in-network with many PPO plans. Coverage varies by exact plan, state, deductible, copay, and coinsurance. Use the plan checker and confirm with the insurer. Medicare beneficiaries may self-pay but cannot submit claims; Medicaid and Medi-Cal patients cannot be accepted even as self-pay.^[9][17]

Is Josie's HRT compounded?

Yes. The current public HRT catalogue contains an estradiol cream, estradiol patch, progesterone-and-estradiol body cream, and progesterone-and-estradiol vaginal cream, and every product page labels the product compounded. Josie states compounded HRT is not FDA-approved.^[1]

Is Josie's estradiol patch FDA-approved?

No, according to the current public page. It is labeled “Compounded HRT · Transdermal,” and the FAQ says compounded medications are not FDA-approved. Ask for the dispensing pharmacy, strength, dose, and finished-product status before paying.^[2]

Does Josie prescribe oral progesterone?

No oral progesterone product is published in Josie's HRT catalogue. The patch page says progesterone would be prescribed separately if needed, but the catalogue does not show the product, price, route, or fulfillment path. A licensed clinician may prescribe outside the catalogue; ask directly before assuming either way.^[2][1]

Does Midi prescribe FDA-approved hormones?

Yes, in its standard HRT lane. Midi lists FDA-approved prescription forms including pills, patches, vaginal rings, creams, and gels. It also sells separate compounded Custom Rx products. “Midi is FDA-approved-only” would be inaccurate; the standard and custom lanes need to remain separate.^[10][11]

Does Midi prescribe testosterone?

Midi offers compounded testosterone cream starting at $100 for a 90-day supply in 24 states plus the District of Columbia. Testosterone is a Schedule III controlled substance in the United States and requires a valid prescription. Midi's program requires a clinician evaluation plus baseline lab work, with follow-up blood draws ordered as needed.^[14][34]

Do I need blood tests before starting HRT at either company?

Not as a universal rule for standard menopause HRT. Josie says labs may be recommended based on history; Midi orders tests when clinically indicated and does not include them in the visit price. The proposed medication and clinical situation can change the answer. Midi's testosterone program specifically requires baseline lab work, with follow-up blood draws ordered as needed.^[1][18][14]

Can I use Josie and Midi at the same time?

You can receive care from more than one clinician, but every prescriber needs a complete medication list and needs to know who is managing which hormone. Do not use overlapping hormone prescriptions from clinicians who are unaware of one another. The cleaner approach is to choose one clinician to coordinate the hormone plan and involve other specialists openly when needed.

What is the $80 Josie fee?

Josie's product FAQs say there is no upfront intake fee, but an $80 consultation fee applies if a licensed provider approves the care plan and the patient then chooses not to proceed with treatment. The practical takeaway is to get your pharmacy, formulation, dose-disclosure, cancellation, and refund questions answered before approval.^[3]

Can I cancel Josie?

The product pages say “cancel anytime,” but the public Terms do not explain cancellation mechanics, refunds, auto-renewal, or reordering. Ask support in writing what cancellation stops and whether the three-month plan renews automatically before authorizing payment.^[6][2]

Can I cancel Midi?

Appointments should be canceled or rescheduled at least 24 hours ahead to avoid a fee. Standard visits are billed per encounter, but Midi's Terms say certain products and services may renew automatically. The Terms contain a two-day cutoff in the general prescription-subscription section and a three-business-day cutoff in the store-subscription section, so read the exact product and checkout terms for any recurring item.^[19][16]

How fast will I get medication?

Josie says most patients hear from a provider within 24 to 48 hours and that prescribed medication ships free from a licensed pharmacy. That is a provider response estimate, not a guaranteed delivery date. Midi's timing depends on appointment availability, the clinical decision, any required tests, and the pharmacy or Custom Rx fulfillment path.^[8][10]

What if my symptoms are mostly vaginal dryness or painful sex?

Midi's standard lane offers FDA-approved local vaginal options through a pharmacy, while Josie offers a compounded progesterone-and-estradiol vaginal cream for $299 per three months. Midi also has a separate compounded DHEA/estradiol cream for the external vulva at $90 per 30 days. Do not compare those three paths as though they are the same product or route.^{[5][15][13][10]}

Did Josie get an FDA warning letter?

Yes. The FDA issued a warning letter on 20 February 2026 about marketing of compounded semaglutide and tirzepatide. It did not concern the safety of Josie's HRT products. Josie was one of 30 telehealth firms named in the FDA's announced compounded-GLP-1 marketing campaign. A warning letter is not a recall, fine, or final finding of liability.^[35][36]

Did Midi face an advertising challenge?

Yes. On 25 February 2026, the National Advertising Division reported that Midi permanently discontinued a challenged Instagram claim during a routine-monitoring inquiry. NAD did not review the merits after the claim was discontinued. The matter did not concern HRT-product safety.^[37]

Can Medicare or Medicaid patients use Midi?

Medicare beneficiaries may use Midi as self-pay patients but cannot submit claims for visits, medications, labs, or associated services. Medicaid and Medi-Cal patients cannot use Midi even as self-pay. An older Midi article still says Medicare patients cannot be treated, but current 2026 pricing and help pages say they can self-pay; confirm the current rule with support before booking.^[17][21]

---

Still not sure which HRT program is right for you? Take The HRT Index's free Find My HRT Path quiz — about 90 seconds.

---

Sources and verification record

Provider pricing, products, policies, state statements, and help-center claims were checked on 21 August 2026 unless a different publication or update date is shown. Review counts and TrustScores are point-in-time figures and should be rechecked before any later publication update.

¹ Josie — Hormone Replacement Therapy category, read 21 Aug 2026.

² Josie — Estradiol Patch, read 21 Aug 2026.

³ Josie — Estradiol Cream, read 21 Aug 2026.

⁴ Josie — Progesterone + Estradiol Body Cream, read 21 Aug 2026.

⁵ Josie — Progesterone + Estradiol Vaginal Cream, read 21 Aug 2026.

⁶ Josie — Terms of Service, last updated 15 Jan 2026; read 21 Aug 2026.

⁷ Josie — About, read 21 Aug 2026.

⁸ Josie — Homepage and FAQ, read 21 Aug 2026.

⁹ Midi Health — Pricing & Insurance, read 21 Aug 2026.

¹⁰ Midi Health — Hormone Replacement Therapy, read 21 Aug 2026.

¹¹ Midi Health — Custom Rx Store, read 21 Aug 2026.

¹² Midi Health — Custom Rx Progesterone, read 21 Aug 2026.

¹³ Midi Health — Custom Rx DHEA/Estradiol Cream, read 21 Aug 2026.

¹⁴ Midi Health — Custom Rx Testosterone, read 21 Aug 2026.

¹⁵ Midi Health — Benefits of Vaginal Estrogen, read 21 Aug 2026.

¹⁶ Midi Health — Terms and Conditions, last updated 23 Jul 2026; read 21 Aug 2026.

¹⁷ Midi Health Help Center — Medicare and Medicaid self-pay eligibility, updated 5 May 2026; read 21 Aug 2026.

¹⁸ Midi Health Help Center — How much will my appointment cost?, read 21 Aug 2026.

¹⁹ Midi Health Help Center — Cancel or reschedule a visit, read 21 Aug 2026.

²⁰ Midi Health Help Center — Midi Portal and Patient Portal, updated 5 May 2026; read 21 Aug 2026.

²¹ Midi Health — How Much Does HRT Cost?, published 22 Aug 2024 and updated 27 Dec 2024; read 21 Aug 2026.

²² Midi Health — Meet Our Clinicians, read 21 Aug 2026.

²³ NCQA — Midi Health Credentialing Accreditation, checked 21 Aug 2026.

²⁴ NPPES NPI Registry — Ana Lisa Carr, NPI 1689841744, checked 21 Aug 2026.

²⁵ Trustpilot — Join Josie reviews, checked 21 Aug 2026.

²⁶ Trustpilot — Midi Health reviews, checked 21 Aug 2026.

²⁷ US FDA — Menopause, checked 21 Aug 2026.

²⁸ The Menopause Society — Hormone Therapy, checked 21 Aug 2026.

²⁹ The Menopause Society — 2022 Hormone Therapy Position Statement.

³⁰ ACOG — Compounded Bioidentical Menopausal Hormone Therapy, Clinical Consensus, Nov 2023.

³¹ British Menopause Society — Progestogens and Endometrial Protection, May 2026.

³² Stute et al. — The impact of micronized progesterone on the endometrium, Climacteric. 2016;19(4):316–328.

³³ NIH DiscoverWHR — Menopause Research Overview, checked 21 Aug 2026.

³⁴ US Drug Enforcement Administration — Controlled Substance Schedules, checked 21 Aug 2026.

³⁵ US FDA — Warning Letter to Join Josie, MARCS-CMS 717986, 20 Feb 2026.

³⁶ US FDA — FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s, 3 Mar 2026.

³⁷ BBB National Programs, National Advertising Division — Midi Health Discontinues Menopause Care Claims, 25 Feb 2026.

Prices, formularies, insurance participation, state availability, terms, and review counts can change. Recheck provider pages and primary records before changing the visible verification date.